Altamira Therapeutics (CYTO) shares were down about 5% in Wednesday's premarket activity after it priced a public offering of 5.6 million common shares and two tranches of pre-funded warrants to purchase up to 11.2 million shares at $0.72 per share or warrant.
The offering is expected to close Thursday.
The company intends to use net proceeds from the offering for general corporate purposes.
Price: 0.7520, Change: -0.04, Percent Change: -4.79
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。